The non-invasive neurostimulation market offers innovative treatment options for neurological disorders through painless electrical stimulation of the brain without surgery. These devices and techniques help modulate brain activity and function to relieve symptoms. The market comprises devices that use technologies such as Transcranial Magnetic Stimulation (TMS), Transcranial Current Stimulation (tCS), and Focused Ultrasound (FUS). Non-invasive neurostimulation devices are safe, cost-effective alternatives to medications for conditions such as depression, chronic pain, Parkinson's disease, and epilepsy.
The non-invasive neurostimulation devices market is estimated to be valued at USD 1.3 Bn in 2024 and is expected to reach USD 2.8 Bn by 2031, growing at a compound annual growth rate (CAGR) of 11.5% from 2024 to 2031.
Growing prevalence of neurological and psychiatric disorders, minimal risks associated with Non-Invasive Neurostimulation Devices Market, and favorable reimbursement are major factors driving market growth.
Key players operating in the non-invasive neurostimulation market are Neuronix, Neurosigma, Boston Scientific Corporation, Medtronic plc, St. Jude Medical, Jabatronic, and Delvalle Square.
The market is witnessing significant demand due to the growing geriatric population suffering from neurological disorders. Technological advancements have enabled the development of precise and targeted neurostimulation systems for conditions like Alzheimer's disease and migraines with minimal side effects.
The rising prevalence of neurological and psychiatric disorders is a major factor driving the demand for non-invasive neurostimulation therapies. Technological advancements are allowing for targeted stimulation approaches with greater accuracy and minimal side effects. This includes the ability to stimulate deeper brain structures for hard to treat conditions like Alzheimer's disease and migraines.
Technological advancements are allowing for more targeted neurostimulation approaches with greater accuracy and minimal side effects. This includes the ability to non-invasively stimulate deeper brain structures for challenging to treat conditions like Alzheimer's disease and migraines. The adoption of digital technologies is also allowing for remote and personalized neurostimulation treatments through cloud-based infrastructure and AI.
Market Trends
- Increased adoption of wearable and remote neurostimulation devices: Manufacturers are developing discreet and wearable devices that can provide neurostimulation on the go for conditions like depression and chronic pain. This allows for increased accessibility and personalized treatment regiments.
- Integration with digital technologies: Non-invasive neurostimulation systems are being integrated with technologies like AI, cloud infrastructure, smartphones to allow for digital biomarkers, remote monitoring and personalized stimulation protocols.
Market Opportunities
- Emerging applications in neurorehabilitation: Non-invasive brain stimulation holds potential for facilitating neuroplasticity and motor recovery in patients of stroke, spinal cord injury, and traumatic brain injury.
- Growth opportunities in developing markets: Markets in Asia Pacific and Latin America are expected to provide high growth opportunities owing to rising healthcare budgets, growing awareness and increasing prevalence of neurological disorders. Partnerships with local players will be crucial.
Impact of COVID-19 on the growth of Non-Invasive Neurostimulation Market
The COVID-19 pandemic has significantly impacted the growth of the non-invasive neurostimulation market. The imposition of lockdowns and social distancing measures led to disruptions in hospital operations and restricted non-essential medical procedures including neurostimulation therapies. This resulted in a decline in demand and postponed treatments. However, with remote patient monitoring capabilities and launch of online therapy programs, major players attempted to minimize the pandemic effects.
In the pre-COVID era, the market was growing at a steady pace owing to the rising geriatric population suffering from neurological disorders and growing awareness. The innovative product launches by key companies expanding indications also supported the market expansion. But the pandemic temporarily halted this growth trajectory. With resumption of healthcare services and relaxation of restrictions in 2021, the market is witnessing a rebound.
To regain the lost momentum, companies are focusing on establishing alternative care delivery models, telehealth integrations, and investments in R&D to develop cost-effective home therapies. Partnerships with digital health firms for remote patient monitoring and support will help sustain growth in the coming years. Regaining patient confidence through extensive safety protocols and guidelines issued by medical societies is also crucial. If the pandemic situation stabilizes, analysts project that the market will surpass pre-COVID projections by 2023-24 with accelerated technology advancements and new indications cleared.
In terms of geographical market concentration, North America holds the major share currently in the non-invasive neurostimulation market due to advanced healthcare infrastructure, availability of reimbursements, and presence of key industry players. Countries like the US and copyright have witnessed increased adoption of non-invasive devices for treating neurological and psychiatric conditions.
Get more insights on: Non-Invasive Neurostimulation Device Market
Get this Report in Japanese Language: 非侵襲性神経刺激装置市場
Get this Report in Korean Language: 비침습적 신경 자극 장치 시장
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)